| Excluded study |
Comparison |
Existing review |
| Alberti 1999 |
Valproate + antipsychotics versus gabapentin + antipsychotics in schizoaffective, bipolar and schizophrenic disorders |
Carta 2003; Perugi 2004; Goodman 2006
|
| Bersudsky 2010 |
Valnoctamide + risperidone versus placebo + risperidone in mania or schizoaffective disorder |
Bailer 2012; Konstantinos 2012
|
| Centorrino 1994 |
Clozapine + valproate in schizophrenia |
Pantelis 1996; Freeman 1998; Balen 1999; Davis 2000; Baethge 2003; Stahl 2004; Besag 2006; Tranulis 2006; Sommer 2012
|
| Haupt 2007 |
Valproate + antipsychotics versus antipsychotic monotherapy in schizophrenia
|
Probably relevant for a new review |
| Ma 2010 |
Magnesium valproate + risperidone versus risperidone monotherapy in schizophrenia with impulsive and aggressive symptoms |
Probably relevant for a new review |
| Monfort 1991 |
Valproate + diazepam versus chlorpromazine in schizophrenia or schizophreniform disorder |
Probably relevant for a new review |
| NCT00183443 |
Divalproex‐extended release (DV‐ER) + lithium versus DV‐ER + quetiapine versus DV‐ER + placebo in mania |
Probably relevant for a new review |
| Ping 1994 |
Sodium valproate versus clozapine versus sodium valproate + clozapine in schizophrenia |
Probably relevant for a new review |
| Raja 2000 |
Antipsychotics versus valproate + antipsychotics in schizophrenia, bipolar, schizoaffective disorder, unipolar depression, personality disorder, mental retardation |
Crowhurst 2002; Adams 2014; Pajonk 2005
|
| Rifang 2001 |
Sodium valproate + chlorpromazine versus chlorpromazine monotherapy in schizophrenia |
Probably relevant for a new review |
| Zhu 2005 |
Valproate + antipsychotics versus clonazepam + antipsychotics in schizophrenia |
Probably relevant for a new review |
